Literature DB >> 11378041

Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis.

P M Hanno1, G R Sant.   

Abstract

In October 2000, the National Institute of Diabetes and Digestive and Kidney Diseases and the Interstitial Cystitis Association held a joint meeting in Minneapolis, Minnesota. Clinical highlights from this meeting are reviewed. The general state of interstitial cystitis from the vantage point of the clinician is discussed, as well as epidemiologic advances, new concepts in markers for interstitial cystitis, and new treatment strategies. Although there are no breakthroughs in finding a cure for this disorder, potential major changes in methods of diagnosis and new forms of therapy are in the offing.

Entities:  

Mesh：

Year:  2001        PMID： 11378041     DOI： 10.1016/s0090-4295(01)01112-8

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  24 in total

1.  Role of c-Jun N-terminal kinase (JNK) activation in micturition reflexes in cyclophosphamide (CYP)-induced cystitis in female rats.

Authors:  C Dugan; S Malley; L Arms; V May; M A Vizzard
Journal:  J Mol Neurosci       Date:  2014-04-26       Impact factor: 3.444

2.  Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.

Authors:  Yi Gao; Limin Liao
Journal:  Int Urogynecol J       Date:  2015-02-18       Impact factor: 2.894

3.  Intravesical PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in NGF-OE Mice.

Authors:  Beatrice M Girard; Susan E Malley; Morgan M Mathews; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2016-05-04       Impact factor: 3.444

4.  Effects of CYP-Induced Cystitis on Growth Factors and Associated Receptor Expression in Micturition Pathways in Mice with Chronic Overexpression of NGF in Urothelium.

Authors:  Beatrice M Girard; Susan Malley; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2016-06-03       Impact factor: 3.444

Review 5.  PACAP/PAC1 Expression and Function in Micturition Pathways.

Authors:  Jacqueline Ojala; Katharine Tooke; Harrison Hsiang; Beatrice M Girard; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2018-09-27       Impact factor: 3.444

6.  Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Dipnarine Maharaj; Gayathri Srinivasan; Sarah Makepeace; Christopher J Hickey; Jacqueline Gouvea
Journal:  J Pers Med       Date:  2021-04-24

7.  Intrabladder PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in Mice Exposed to Repeated Variate Stress (RVS).

Authors:  Beatrice M Girard; Susan E Campbell; Katharine I Beca; Megan Perkins; Harrison Hsiang; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2020-07-01       Impact factor: 2.866

8.  CXCL10 blockade protects mice from cyclophosphamide-induced cystitis.

Authors:  Senthilkumar K Sakthivel; Udai P Singh; Shailesh Singh; Dennis D Taub; Kristian R Novakovic; James W Lillard
Journal:  J Immune Based Ther Vaccines       Date:  2008-10-28

9.  O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Yuh-Chen Kuo; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2015-07-30       Impact factor: 4.546

10.  Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.

Authors:  Yuan-Hong Jiang; Chung-Hsin Peng; Hsin-Tzu Liu; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.